Cargando…

Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices

INTRODUCTION: High rectal doses are associated with increased toxicity. A rectal displacement device (RDD) reduces rectal dose in prostate stereotactic body radiation therapy (SBRT). This study investigates any dosimetric difference between two methods of rectal displacement (Rectafix and SpaceOAR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilton, Lee, Richardson, Matthew, Keats, Sarah, Legge, Kimberley, Hanlon, Mary‐Claire, Arumugam, Sankar, Hunter, Perry, Evans, Tiffany‐Jane, Sidhom, Mark, Martin, Jarad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715268/ https://www.ncbi.nlm.nih.gov/pubmed/28786219 http://dx.doi.org/10.1002/jmrs.238

Ejemplares similares

Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement
por: Legge, Kimberley, et al.
Publicado: (2017)

Real‐time intrafraction prostate motion during linac based stereotactic radiotherapy with rectal displacement
por: Legge, Kimberley, et al.
Publicado: (2017)

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
por: Richardson, Matthew, et al.
Publicado: (2018)

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)
por: Pryor, David, et al.
Publicado: (2019)

Reducing the margin in prostate radiotherapy: optimizing radiotherapy with a general-purpose linear accelerator using an in-house position monitoring system
por: Arumugam, Sankar, et al.
Publicado: (2023)

Does setup on rectal wall improve rectal cancer boost radiotherapy?
por: Kleijnen, Jean-Paul J. E., et al.
Publicado: (2018)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Stereotactic MR-guided adaptive radiotherapy (SMART) for primary rectal cancer: evaluation of early toxicity and pathological response
por: Castelluccia, Alessandra, et al.
Publicado: (2023)

Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins
por: Boldrini, Luca, et al.
Publicado: (2023)

Rectal prolapse following short-course radiotherapy for rectal cancer: report of a case
por: Nocera, Fabio, et al.
Publicado: (2020)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Intraoperative Radiotherapy for Locally Advanced Rectal Cancer
por: Kang, Min Kyu, et al.
Publicado: (2010)

Rectal retractor in prostate radiotherapy: pros and cons
por: Ghaffari, Hamed, et al.
Publicado: (2022)

Quantifying displacement of urogenital organs after abdominoperineal resection for rectal cancer
por: Sharabiany, Sarah, et al.
Publicado: (2021)

CT-Only Radiotherapy: An Exploratory Study for Automatic Dose Prediction on Rectal Cancer Patients Via Deep Adversarial Network
por: Cui, Jiaqi, et al.
Publicado: (2022)

An Update on Preoperative Radiotherapy for Locally Advanced Rectal Cancer
por: Yeo, Seung-Gu, et al.
Publicado: (2012)

Radiotherapy Response in Microsatellite Instability Related Rectal Cancer
por: Shin, Joo-Shik, et al.
Publicado: (2013)

Intra-rectal use of epinephrine in radiotherapy of prostate cancer
por: Qin, Shang-Bin, et al.
Publicado: (2019)

Short-Course Radiotherapy in Locally Advanced Rectal Cancer
por: Cambray, Maria, et al.
Publicado: (2020)

Rectal-cancer radiotherapy damages the perineal muscle floor
por: Reggiani Bonetti, Luca, et al.
Publicado: (2020)

Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic
por: Lewis, Shirley, et al.
Publicado: (2020)

Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020
por: Hanna, C.R., et al.
Publicado: (2021)

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy
por: Koo, Kendrick, et al.
Publicado: (2021)

Mechanisms of microRNA action in rectal cancer radiotherapy
por: Zhu, Lili, et al.
Publicado: (2022)

Advantages of mini-multileaf in stereotactic radiotherapy
por: Kurup, P. G. G., et al.
Publicado: (2007)

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
por: Dubouloz, Angèle, et al.
Publicado: (2018)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Rectal Syphilis Mimicking Rectal Cancer
por: Cha, Jae Myung, et al.
Publicado: (2010)

PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy - a study in a Swedish rectal cancer trial of preoperative radiotherapy
por: Holmqvist, Annica, et al.
Publicado: (2012)

Technical note: TROG 15.01 SPARK trial multi‐institutional imaging dose measurement
por: Legge, Kimberley, et al.
Publicado: (2017)

Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy
por: Chen, Jiawei, et al.
Publicado: (2018)

Minimal Rectal Toxicity in the Setting of Comorbid Crohn’s Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer
por: Singh, Raj, et al.
Publicado: (2017)

Rectal prolapse traumatizes rectal neuromuscular microstructure explaining persistent rectal dysfunction
por: Kraemer, Matthias, et al.
Publicado: (2016)

Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity
por: Smith, Thomas, et al.
Publicado: (2020)

Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
por: Allen, D. C., et al.
Publicado: (1999)

Direct costs of radiotherapy for rectal cancer: a microcosting study
por: Hanly, Paul, et al.
Publicado: (2015)

Radiotherapy for stage IIA rectal cancer may not benefit all
por: Hu, Xiang, et al.
Publicado: (2017)

Controversial issues in radiotherapy for rectal cancer: a systematic review
por: Kim, Jong Hoon
Publicado: (2017)

Online MR guided radiotherapy for rectal cancer. New opportunities
por: Gani, C., et al.
Publicado: (2019)

Nomogram to predict rectal toxicity following prostate cancer radiotherapy
por: Delobel, Jean-Bernard, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k3noj0ljuqg5oo0ieio9l228k3